Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Piperno-Neumann

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
BMC Cancer|December 1, 2005
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II studyDjelila Allouache, Sulochana R Gawande, Michele Tubiana-Hulin, et al.
Bulletin Du Cancer|July 8, 2025
Management of metastatic uveal melanoma: French expert consensus guidelinesManuel Rodrigues, Vincent Servois, Pascale Mariani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2017
Phase-II trials in osteosarcoma recurrences: A systematic review of past experienceNatacha Omer, Marie-Cécile Le Deley, Sophie Piperno-Neumann, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2021
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variantsArnaud de la Fouchardiere, Willeke Blokx, Léon C van Kempen, et al.
Pediatric Blood & Cancer|April 22, 2022
Prognostic impact of pulmonary nodules diagnosed at initial presentation in patients with osteosarcomaSabine Irtan, Jean Donadieu, Hélène Pacquement, et al.
Investigative Ophthalmology & Visual Science|April 21, 2016
Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14)Selma Maacha, Océane Anezo, Malika Foy, et al.
Oncoimmunology|September 12, 2022
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patientsHélène Salaün, Leanne de Koning, Mathilde Saint-Ghislain, et al.
Cancers|June 26, 2019
Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRIPascale Mariani, Sylvain Dureau, Alexia Savignoni, et al.
The Oncologist|February 26, 2016
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal MelanomaSophie Piperno-Neumann, Alhassane Diallo, Marie-Christine Etienne-Grimaldi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 28, 2017
The biological and prognostic significance of angiotropism in uveal melanomaRaymond L Barnhill, Mengliang Ye, Aude Batistella, et al.
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
BMC Cancer|December 1, 2005
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II studyDjelila Allouache, Sulochana R Gawande, Michele Tubiana-Hulin, et al.
Bulletin Du Cancer|July 8, 2025
Management of metastatic uveal melanoma: French expert consensus guidelinesManuel Rodrigues, Vincent Servois, Pascale Mariani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2017
Phase-II trials in osteosarcoma recurrences: A systematic review of past experienceNatacha Omer, Marie-Cécile Le Deley, Sophie Piperno-Neumann, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2021
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variantsArnaud de la Fouchardiere, Willeke Blokx, Léon C van Kempen, et al.
Pediatric Blood & Cancer|April 22, 2022
Prognostic impact of pulmonary nodules diagnosed at initial presentation in patients with osteosarcomaSabine Irtan, Jean Donadieu, Hélène Pacquement, et al.
Investigative Ophthalmology & Visual Science|April 21, 2016
Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14)Selma Maacha, Océane Anezo, Malika Foy, et al.
Oncoimmunology|September 12, 2022
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patientsHélène Salaün, Leanne de Koning, Mathilde Saint-Ghislain, et al.
Cancers|June 26, 2019
Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRIPascale Mariani, Sylvain Dureau, Alexia Savignoni, et al.
The Oncologist|February 26, 2016
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal MelanomaSophie Piperno-Neumann, Alhassane Diallo, Marie-Christine Etienne-Grimaldi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 28, 2017
The biological and prognostic significance of angiotropism in uveal melanomaRaymond L Barnhill, Mengliang Ye, Aude Batistella, et al.
Pageof 15